[{"id":"207f3b6a-911f-40e1-af15-23413b54bd20","acronym":"","url":"https://clinicaltrials.gov/study/NCT06013111","created_at":"2023-08-28T14:08:22.937Z","updated_at":"2024-07-02T16:35:18.323Z","phase":"Phase 1","brief_title":"An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors","source_id_and_acronym":"NCT06013111","lead_sponsor":"China Medical University, China","biomarkers":" CEACAM5","pipe":" | ","alterations":" CEACAM5 expression • CEACAM5 overexpression","tags":["CEACAM5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CEACAM5 expression • CEACAM5 overexpression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • anti-CEA-CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 9","initiation":"Initiation: 10/23/2023","start_date":" 10/23/2023","primary_txt":" Primary completion: 09/01/2026","primary_completion_date":" 09/01/2026","study_txt":" Completion: 09/01/2026","study_completion_date":" 09/01/2026","last_update_posted":"2024-02-21"}]